科研之友
微信
新浪微博
Facebook
分享链接
摘要
Due to the potential toxicity of lenalidomide, a highly potent and severe life threatening human birth defect, a lot of precaution should to be taken in handling such kind of drugs. Lenalidomide drug-excipient blend from the capsule pharmaceutical dosage form was subjected to different ICH prescribed stress conditions of thermal stress, pH hydrolysis, oxidation and photolysis. The drug was found to be stable only at photolysis and thermal stress, while it was extremely susceptible to other stressing conditions especially it showed extensive degradation under alkali conditions. For establishment of stability-indicating method, the rate of degradation in solutions in which different degradation products were formed were monitored at different time intervals, by using different concentrations of stressing reagents, and the separations was optimized by varying the LC conditions. An acceptable separation was achieved through a multi-step gradient elution using an ACE (R) C18, 150x4.6mm i.d, 3m, stainless steel analytical column and a mobile phase comprising of 0.01M phosphate buffer (pH, 2.0 +/- 0.1) as mobile phase-A, and a mixture of water and acetonitrile in the ratio of 200:800 (v/v) as mobile phase-B, with a flow rate and detection wavelength being 1.0mLmin-1 and 220nm respectively. The major degradation products appeared at relative retention times (RRT) of 0.75, 0.86, 0.96, 1.33, 1.52, 1.99, 2.04, 2.62 and 2.66 respectively.
- 出版日期2010
